Publication date: Aug 31, 2024
Elevated blood glucose concentration, also known as hyperglycemia, has been identified as a significant factor influencing the prognosis of COVID-19, alongside the impact of the SARS-CoV-2 infection itself. This research is a cross-sectional investigation that examined the relationship between COVID-19 and hyperglycemia in patients admitted to Afzalipour Hospital in Kerman, Iran, from July to September 2021. A standardized data sheet was used to capture demographic data (age, gender) and laboratory information (blood sugar, arterial blood oxygen saturation, and C-reactive protein (CRP)) upon admission. The present research evaluated a total of 300 individuals diagnosed with COVID-19, with an average age of 50. 19ā+/-ā15. 55 years. Among these patients, the majority were male, accounting for 51. 67% of the total. Hyperglycemia was seen in 21. 67% of patients, but less than 20% had new-onset diabetes. Individuals exhibiting hyperglycemia were typical of advanced age (Pā
Concepts | Keywords |
---|---|
Accounting | COVID-19 |
Diabetes | Hyperglycemia |
Iran | New-onset diabetes |
July | Prognosis |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | hyperglycemia |
disease | IDO | blood |
drug | DRUGBANK | Dextrose unspecified form |
pathway | REACTOME | SARS-CoV-2 Infection |
drug | DRUGBANK | Oxygen |
disease | MESH | Long Covid |